DEF 14A: NorthStar Healthcare Income Sets Date for 2024 Annual Stockholder Meeting

Sentiment:

Proxy Statement


NorthStar Healthcare Income will hold its 2024 annual meeting of stockholders virtually on June 20, 2024, to vote on director elections, executive compensation, and auditor ratification.

Worse than expectedThe company reported a net loss of approximately $160 million in 2023, compared to approximately $55 million in 2022.

Summary

  • NorthStar Healthcare Income, Inc. will hold its 2024 annual meeting of stockholders on June 20, 2024, as a virtual-only meeting.
  • Stockholders of record as of April 10, 2024, are eligible to vote.
  • The meeting will address the election of four directors, an advisory vote on executive compensation, and the ratification of Grant Thornton LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
  • Proxy materials are being distributed on or about April 15, 2024, and are available online at www.proxyvote.com.
  • Broadridge Financial Solutions has been retained to assist in the distribution of proxy materials and the solicitation of proxies for a fee of approximately $65,000, plus expenses.
  • The Board recommends voting for the election of the director nominees, for the approval of executive compensation, and for the ratification of Grant Thornton as the independent auditor.

Sentiment

Score: 5

Explanation: The document is primarily informational, outlining the agenda and procedures for the annual meeting. While there are positive aspects like the increase in net operating income, the overall sentiment is neutral due to the net loss and strategic default on certain assets.

Positives

  • The company is providing a virtual meeting option for stockholders.
  • The Board is recommending votes in favor of all proposals.
  • The company has successfully transitioned to an internalized structure, reducing corporate expenses by $8.2 million in 2023.
  • Net operating income from direct investments increased by more than 30% in 2023.
  • The company completed the final sale of assets in the Espresso joint venture, resulting in total distributions of $95.1 million compared to a $55.1 million investment.

Negatives

  • The company reported a net loss of approximately $160 million in 2023.
  • The company strategically defaulted on borrowings underlying certain assets in the Rochester portfolio due to sustained negative cash flow.

Risks

  • The company faces risks inherent in the seniors housing industry.
  • The company's success depends on its ability to manage its properties effectively.
  • The company's performance is subject to economic conditions and market trends.
  • The company's compensation recoupment policy allows for the recapture of excess incentive compensation under certain circumstances.

Future Outlook

The company does not provide specific financial guidance but outlines strategic objectives including growing operating income and advancing disposition strategies.

Management Comments

  • The Board believes it is important to select our Chairman and our Chief Executive Officer in the manner it considers to be in our best interests and in the best interests of our stockholders at any given point in time.
  • The members of our Board possess considerable business experience and in-depth knowledge of the issues we face, and are therefore in the best position to evaluate our needs and how best to organize our leadership structure to meet those needs.

Industry Context

The company operates in the seniors housing industry, which is subject to various economic and demographic trends. The proxy statement does not provide specific details on how NorthStar Healthcare Income compares to its direct competitors but mentions the use of a peer group for compensation benchmarking.

Comparison to Industry Standards

  • The peer group established by our Special Committee in 2022 consisted of participating REITs included in the 2021 NAREIT Compensation Survey with less than $1.5 billion of total capitalization.
  • While certain REITs included in our total market capitalization range from the 2021 NAREIT Compensation Survey may not be direct competitors with us, our Special Committee believed that such peer group was reasonably representative of our market for executive talent in the commercial real estate space and believed a broader peer group would better facilitate the design of the Companys initial compensation program.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
General Counsel and SecretaryNicholas R. Balzo (Secretary)Ann B. HarringtonOctober 1, 2023Appointment

Related Party Transactions

  • In June 2023, the company sold its minority interests in the Healthcare GA Holdings, General Partnership and Eclipse Health, General Partnership to its Former Sponsor for equity held by the Former Sponsor and its affiliates in the Company, including 9,709,553 shares of common stock, 100 common units in our operating partnership and 100 special units in our operating partnership.

Stakeholder Impact

  • The outcome of the votes on director elections and executive compensation will directly impact shareholders.
  • The company's performance and strategic decisions affect employees, customers (residents of senior housing facilities), and creditors.

Next Steps

  • Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
  • The company will file the voting results in a Current Report on Form 8-K within four business days of the annual meeting.
  • The Compensation Committee will review executive compensation annually to assess if adjustments are necessary.

Key Dates

DateDescription
January 1, 2023Effective date for revised independent director compensation plan.
January 25, 2023Compensation Committee approved revised Independent Directors Compensation Plan for 2023.
March 22, 2023Amendment to the transition services agreement with the Former Advisor.
June 2023Sale of minority interests in Healthcare GA Holdings and Eclipse Health to the Former Sponsor.
June 30, 2023Date through which Mr. Balzo was required to continue service to receive a retention award.
July 1, 2023Effective date of Mr. Young's base salary increase.
October 1, 2023Ann B. Harrington appointed as General Counsel and Secretary.
December 31, 2023End of fiscal year 2023; Transition services agreement effectively terminated.
April 10, 2024Record date for determining stockholders eligible to vote at the annual meeting.
April 15, 2024Approximate date of mailing proxy materials to stockholders.
June 20, 2024Date of the 2024 annual meeting of stockholders.
December 16, 2024Deadline for receipt of stockholder proposals for inclusion in the 2025 proxy statement.
April 21, 2025Deadline for stockholders to provide written notice of intent to solicit proxies in support of director nominees other than the Company's nominees for the 2025 annual meeting of stockholders.
June 20, 2025Date of the 2025 annual meeting of stockholders.

Keywords

annual meeting, proxy statement, directors, executive compensation, Grant Thornton, stockholders, virtual meeting, healthcare, NorthStar Healthcare Income, Internalization

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.